Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy. (2021)
Attributed to:
Oxford P2D: From Technologies to Therapies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/acn3.51417
PubMed Identifier: 34453498
Publication URI: http://europepmc.org/abstract/MED/34453498
Type: Journal Article/Review
Volume: 8
Parent Publication: Annals of clinical and translational neurology
Issue: 10
ISSN: 2328-9503